Avra Laboratories Pvt. Ltd.
About Avra Laboratories Pvt. Ltd.
Categories
-
IN -
2015On CPHI since
Products from Avra Laboratories Pvt. Ltd. (3)
-
Product 10-hydroxycamptothecin
Avra Laboratories is first Company in the world to develop a synthetic route 10-hydroxycamptothecin. manufacturing in USFDA approved facility and support USDMF for regulatory fillings (key intermediate of Topotecan).
-
Product 7-Ethyl-10-hydroxycamptothecin (SN-38)
Avra Laboratories is first Company in the world to develop a synthetic route for manufacturing of camptothecin derivatives. Avra manufacturing 7-Ethyl-10-hydroxycamptothecin (SN-38) in dedicated oncology facility which is approved by USFDA. we support USDMF and regulatory fili... -
Product Irinotecan Hcl
Avra developed an optimal process for the total synthesis of SN-38 and its conversion to Irinotecan Hcl USP and give more purity (Assay) NLT 99%. manufacturing in USFDA approved facility and support regulatory requirements.
USDMF and EDMF available
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance